title: Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities.
abstract: OBJECTIVE
  Radiotherapy (RT) has been the predominant local treatment for Ewing's sarcoma of bone at the University of Florida. Twice-daily hyperfractionated RT was initiated in 1982 to improve local control and functional outcome. This retrospective review compares the results of once-daily vs. twice-daily RT in patients with primary Ewing's sarcoma of an extremity, with emphasis on functional outcome.
  
  
  METHODS
  Between June 1971 and January 1990, 37 patients were treated at the University of Florida for nonmetastatic Ewing's sarcoma of bone with a primary lesion in an extremity. Three patients underwent amputation. Of 34 patients treated with RT, 31 had RT alone and 3 had a combination of RT and local excision. Before 1982, 14 patients received once-daily RT; since 1982, 17 patients have received twice-daily RT. Doses of once-daily RT varied from 47 to 61 Gy at 1.8-2 Gy per fraction. Doses of twice-daily RT varied, depending on the response of the soft-tissue component of the tumor to chemotherapy, and ranged from 50.4 to 60 Gy at 1.2 Gy per fraction. Some patients in the twice-daily RT group also received total body irradiation 1-3 months after local RT as part of a conditioning regimen before marrow-ablative therapy with stem cell rescue. They received either 8 Gy in two once-daily fractions or 12 Gy in six twice-daily fractions. The six patients who received surgery were excluded from local control analysis. Local control rates were calculated using the Kaplan-Meier (actuarial) method. Fifteen patients had a formal functional evaluation.
  
  
  RESULTS
  In the 31 patients treated with RT alone, the actuarial local control rate at 5 years was 81% for patients treated twice daily and 77% for those treated once daily (p = NS). No posttreatment pathologic fractures occurred in patients treated twice daily, whereas five fractures occurred in those treated once daily (p = 0.01). On functional evaluation, less loss in range of motion (15 degrees vs. 28 degrees of loss, p = 0.02) and a lesser degree of muscle atrophy (8% vs. 21% loss in muscle circumference, p = 0.0004) occurred with twice-daily than with once-daily RT. A trend toward less fibrosis and less local alopecia was seen in patients treated twice daily. Patients treated twice daily received a higher Musculoskeletal Tumor Society functional rating (determined by the Department of Orthopaedics) than those treated once daily (29.4 vs. 26.0, p = 0.15).
  
  
  CONCLUSIONS
  Local control rates were similar in the two groups (77% vs. 81%), but functional results were superior in the group treated twice daily.
authors.affiliation: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville 32610-0385, USA.
authors.forename: T W
authors.initials: TW
authors.lastname: Bolek
authors.forename: R B
authors.initials: RB
authors.lastname: Marcus
authors.forename: N P
authors.initials: NP
authors.lastname: Mendenhall
authors.forename: M T
authors.initials: MT
authors.lastname: Scarborough
authors.forename: J
authors.initials: J
authors.lastname: Graham-Pole
mesh_terms: D001859:Bone Neoplasms / Q000503:physiopathology / Q000532:radiotherapy*; D005121:Extremities; D006801:Humans; D011879:Radiotherapy Dosage; D012512:Sarcoma, Ewing / Q000503:physiopathology / Q000532:radiotherapy*